Decreased Infections in Recipients of Unrelated Donor Hematopoietic Cell Transplantation from Donors with an Activating KIR Genotype

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 8, 2010, Pages 1155-1161

  Tomblyn, Marcie ^a   Young, Jo Anne H ^b   Haagenson, Michael D ^c   Klein, John P ^c,d   Trachtenberg, Elizabeth A ^e   Storek, Jan ^f   Spellman, Stephen R ^c   Cooley, Sarah ^b   Miller, Jeffrey S ^b   Weisdorf, Daniel J ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Allogeneic transplantation; Infections; KIR; Unrelated

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CELL FUNCTION; CHILD; DONOR; FEMALE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYCOSIS; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT OUTCOME; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; MYCOSES; RECEPTORS, KIR; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIRUS DISEASES; YOUNG ADULT;

EID: 77954312853     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.02.024     Document Type: Article

References (24)

1. CIBMTR Summary Slides, 2009. Available at: http://www.cibmtr.org/SERVICES/summary_slides.html.
2. Abi-Rached L., Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med 2005, 201:1913-1932.
3. Uhrberg M., Valiante N.M., Shum B.P., et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997, 7:753-763.
4. Lu Z., Zhang B., Chen S., et al. Association of KIR genotypes and haplotypes with susceptibility to chronic hepatitis B virus infection in Chinese Han population. Cell Mol Immunol 2008, 5:457-463.
5. Genetics and the Immune Response. Abstracts of the 35th Annual Scientific Meeting of the Australasian Society for Immunology and the 14th International HLA and Immunogenetics Workshop, Melbourne, Australia, 4-8. Tissue Antigens. 2005;66:343-640.
6. Hsu K.C., Liu X.R., Selvakumar A., Mickelson E., O'Reilly R.J., Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of 6 basic framework haplotypes, each with multiple subsets. J Immunol 2002, 169:5118-5129.
7. Uhrberg M., Parham P., Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002, 54:221-229.
8. Iannello A., Debbeche O., Samarani S., Ahmad A. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. J Leukoc Biol 2008, 84:1-26.
9. Gaudieri S., DeSantis D., McKinnon E., et al. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun 2005, 6:683-690.
10. Martin M.P., Gao X., Lee J.H., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002, 31:429-434.
11. Rauch A., Laird R., McKinnon E., et al. Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue Antigens 2007, 69(Suppl 1):237-240.
12. de Arias A.E., Haworth S.E., Belli L.S., et al. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transpl 2009, 15:390-399.
13. Shilling H.G., McQueen K.L., Cheng N.W., Shizuru J.A., Negrin R.S., Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003, 101:3730-3740.
14. Cooley S., Trachtenberg E., Bergemann T.L., et al. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood 2009, 113:726-732.
15. Cook M., Briggs D., Craddock C., et al. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 2006, 107:1230-1232.
16. Chen C., Busson M., Rocha V., et al. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant 2006, 38:437-444.
17. Houtchens K.A., Nichols R.J., Ladner M.B., et al. High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles. Immunogenetics 2007, 59:525-537.
18. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
19. Weisdorf D., Spellman S., Haagenson M., et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 2008, 14:748-758.
20. Klein J.P., Logan B., Harhoff M., Andersen P.K. Analyzing survival curves at a fixed point in time. Stat Med 2007, 26:4505-4519.
21. Mancusi A., Ruggeri L., McQueen K., Donor Activating K.I.R. Genes and control of infections after haploidentical haematopoietic transplantation. Bone Marrow Transplant 2006, 37:3.
22. Clausen J., Wolf D., Petzer A.L., et al. Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation. Clin Exp Immunol 2007, 148:520-528.
23. Schaffer M., Malmberg K.J., Ringden O., Ljunggren H.G., Remberger M. Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation. Transplantation 2004, 78:1081-1085.
24. Kim D.H., Sohn S.K., Lee N.Y., et al. Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors. Eur J Haematol 2005, 75:299-308.